Skip to search formSkip to main contentSkip to account menu

Pentaxim

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pentavac

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15–18 Months of Age in Mexico: A Randomized…
Background: The live, attenuated, tetravalent dengue vaccine (CYD-TDV) is licensed in a number of dengue endemic countries for… 
2016
2016
The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants
Recommended infant vaccination in Korea includes DTaP-IPV and Hib vaccines administered as separate injections. In this… 
2012
2012
Immunogenicity and safety of a DTaP-IPV//PRP∼T vaccine (Pentaxim) booster dose during the second year of life in Indian children primed with the same vaccine
ObjectiveTo evaluate the immunogenicity and safety of a pentavalent (diphtheria, tetanus, acellular pertussis, inactivated… 
Review
2011
Review
2011
A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP… 
2011
2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for…
2011
2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary…
2011
2011
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of…
OBJECTIVE To assess the immunogenicity and safety data for a pentavalent combination vaccine containing acellular pertussis… 
2011
2011
Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2…
Background and Aims: Assessment of a new, fully liquid, investigational hexavalent DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim, Sanofi… 
2010
2010
Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6…
The objective of this study was to evaluate the immunogenicity and safety of a pentavalent vaccine (Pentaxim) containing… 
2009
2009
Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
This study assessed the booster immune response to a pentavalent combination vaccine containing diphtheria, tetanus, acellular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)